Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Acquisition and Clearance Dynamics of Campylobacter in Children in Low- and Middle-Income Countries

View ORCID ProfileDehao Chen, Arie H. Havelaar, James A. Platts-Mills, Yang Yang
doi: https://doi.org/10.1101/2023.02.06.23285359
Dehao Chen
1Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dehao Chen
Arie H. Havelaar
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
3Department of Animal Sciences, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, FL, USA
4Institute for Sustainable Food Systems, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. Platts-Mills
5Division of Infectious Diseases and International Health, University of Virginia Health System, Charlottesville, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Yang
6Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yang.yang4{at}uga.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The burden of Campylobacter infection is high in children under five years of age in low- and middle-income countries (LMIC), but its acquisition and clearance process is understudied due to scarcity of longitudinal data. We aim to quantify this process using a statistical modeling approach, leveraging data from a multi-nation study.

Methods Motivated by the MAL-ED study in which children from eight low- and middle- income countries were followed up for enteric infections during their first two years of life, we developed a two-stage Markov model to compare the dynamics of acquisition and clearance of Campylobacter in children across countries and to explore antibiotic effectiveness on Campylobacter clearance. This model was validated using simulations and applied to the longitudinal data from MAL-ED.

Findings The clearance rate was higher than the acquisition rate at most sites and times, but the temporal trend of these rates varied across countries. For Campylobacter jejuni/coli, clearance was faster than acquisition under two years of age at all sites. For Campylobacter spp., the acquisition rate surpassed the clearance rate in the second half of the first year in Bangladesh, Pakistan and Tanzania, leading to high prevalence in these countries. Bangladesh had the shortest (28 and 57 days) while Brazil had the longest (328 and 306 days) mean times to acquisition for Campylobacter spp. and C. jejuni/coli, respectively. South Africa had the shortest (10 and 8 days) while Tanzania had the longest (53 and 41 days) mean times to clearance for Campylobacter spp. and C. jejuni/col respectively. The use of macrolides was associated with accelerated clearance of C. jejuni/coli in Bangladesh and Peru and of Campylobacter spp. in Bangladesh and Pakistan. The use of fluoroquinolones showed statistically meaningful effectiveness only in Bangladesh but for both C. jejuni/coli and Campylobacter spp.

Interpretation Higher burden of Campylobacter infection was mainly driven by high acquisition rate that was close to or surpassing the clearance rate. Acquisition usually peaked in 11-17 months in the LMIC setting, indicating the importance of targeting the first year of life for effective intervention.

Funding Bill & Melinda Gates Foundation.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the United States Agency for International Development (USAID) Bureau for Food Security under Agreement #AID-OAA-L-15-00003 as part of Feed the Future Innovation Lab for Livestock Systems, and by the Bill & Melinda Gates Foundation OPP#1175487. Any opinions, findings, conclusions, or recommendations expressed here are those of the authors alone.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of University of Florida waived ethical approval for this work as it is eligible for a non-human determination.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 08, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Acquisition and Clearance Dynamics of Campylobacter in Children in Low- and Middle-Income Countries
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Acquisition and Clearance Dynamics of Campylobacter in Children in Low- and Middle-Income Countries
Dehao Chen, Arie H. Havelaar, James A. Platts-Mills, Yang Yang
medRxiv 2023.02.06.23285359; doi: https://doi.org/10.1101/2023.02.06.23285359
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Acquisition and Clearance Dynamics of Campylobacter in Children in Low- and Middle-Income Countries
Dehao Chen, Arie H. Havelaar, James A. Platts-Mills, Yang Yang
medRxiv 2023.02.06.23285359; doi: https://doi.org/10.1101/2023.02.06.23285359

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)